Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray

被引:48
作者
Iizuka, N
Oka, M
Yamamoto, K
Taruoku, A
Miyamoto, K
Miyamoto, T
Uchimura, S
Hamamoto, Y
Okita, K
机构
[1] Yamaguchi Univ, Sch Med, Dept Bioregulatory Funct, Ube, Yamaguchi 7558505, Japan
[2] Yamaguchi Univ, Sch Med, Dept Surg 2, Ube, Yamaguchi 7558505, Japan
[3] Yamaguchi Univ, Fac Engn, Dept Comp Sci & Syst Engn, Ube, Yamaguchi 7558505, Japan
[4] Yamaguchi Univ, Sch Med, Dept Internal Med 1, Yamaguchi, Japan
关键词
Coptidis rhizoma; herb; berberine; DNA chip; pancreatic cancer;
D O I
10.1002/ijc.11452
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although the physiological actions of many herbs are gradually being elucidated at the molecular level, it remains unclear how individual components of herbs contribute to their biological activities. In the present study, the antiproliferative activity of Coptidis rhizoma, a medicinal herb, and the major component berberine was investigated in 8 human pancreatic cancer cell lines. Gene expression patterns associated with sensitivities to each agent were analyzed with oligonucleotide arrays that comprised approximately 11,000 genes. We used a tetrazolium dye (MTT) assay to determine ID50 values after the 8 cell lines were exposed to the 2 agents for 72 hr. The ID50 value for berberine was correlated positively with that for C. rhizoma (r=0.725, p=0.0401). C. rhizoma killed tumor cells more effectively than purified berberine when normalized to the level of berberine present in the herb. From the oligonucleoticle array data, we selected 20 and 13 genes with strong correlations (r(2)>0.81) to ID50 values for berberine and C. rhizoma, respectively. Among these 33 genes, the levels of expression of 12 were correlated with the ID50 values of both agents, suggesting that these genes are associated with tumor-killing activity of berberine in C. rhizoma. Expression of the remaining 21 genes was correlated with the ID50 value of either purified berberine or C. rhizoma. Thus, we identified common and distinct genes responsible for anti-proliferative activities of purified berberine and C. rhizoma. This strategy may improve our understanding of the actions of herbs with antitumor activities. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:666 / 672
页数:7
相关论文
共 39 条
[1]  
Bonham M, 2002, CANCER RES, V62, P3920
[2]  
Cassileth BR, 1999, CANCER, V86, P1900, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1900::AID-CNCR4>3.3.CO
[3]  
2-U
[4]   CONFORMATIONS, DNA BINDING PARAMETERS, AND ANTI-LEUKEMIC ACTIVITY OF CERTAIN CYTOTOXIC PROTOBERBERINE ALKALOIDS [J].
CUSHMAN, M ;
DEKOW, FW ;
JACOBSEN, LB .
JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (03) :331-333
[5]  
DeRisi J, 1996, NAT GENET, V14, P457
[6]   Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer [J].
DiPaola, RS ;
Zhang, HY ;
Lambert, GH ;
Meeker, R ;
Licitra, E ;
Rafi, MM ;
Zhu, BT ;
Spaulding, H ;
Goodin, S ;
Toledano, MB ;
Hait, WN ;
Gallo, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (12) :785-791
[7]   UNCONVENTIONAL MEDICINE IN THE UNITED-STATES - PREVALENCE, COSTS, AND PATTERNS OF USE [J].
EISENBERG, DM ;
KESSLER, RC ;
FOSTER, C ;
NORLOCK, FE ;
CALKINS, DR ;
DELBANCO, TL .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (04) :246-252
[8]   Inhibition of activator protein 1 activity by berberine in human hepatoma cells [J].
Fukuda, K ;
Hibiya, Y ;
Mutoh, M ;
Koshiji, M ;
Akao, S ;
Fujiwara, H .
PLANTA MEDICA, 1999, 65 (04) :381-383
[9]  
Fukutake M, 1998, BIOL PHARM BULL, V21, P814, DOI 10.1248/bpb.21.814
[10]   Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats [J].
Fukutake, M ;
Miura, N ;
Yamamoto, M ;
Fukuda, K ;
Iijima, O ;
Ishikawa, H ;
Kubo, M ;
Okada, M ;
Komatsu, Y ;
Sasaki, H ;
Wakabayashi, K ;
Ishige, A ;
Amagaya, S .
CANCER LETTERS, 2000, 157 (01) :9-14